Leopoldo Bianconi

Summary

Country: Italy

Publications

  1. ncbi n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study
    Leopoldo Bianconi
    Department of Cardiology, San Filippo Neri Hospital, University of Tor Vergata, Rome, Italy
    Europace 13:174-81. 2011
  2. ncbi Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination
    Leonardo Calo
    Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
    Ital Heart J 4:442-7. 2003
  3. ncbi Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: a prospective and randomized study
    Leonardo Calo
    Division of Cardiology, Policlinico Casilino, ASL RM B, Rome, Italy
    J Am Coll Cardiol 47:2504-12. 2006
  4. ncbi Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion
    Maria Luisa Loricchio
    Cardiology Department, Sandro Pertini Hospital, Rome, Italy
    Am J Cardiol 99:1421-4. 2007
  5. ncbi Atrial flutter and atrial fibrillation: which relationship? New insights into the electrophysiological mechanisms and catheter ablation treatment
    Leonardo Calo
    Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
    Ital Heart J 6:368-73. 2005
  6. ncbi N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial
    Leonardo Calo
    Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
    J Am Coll Cardiol 45:1723-8. 2005
  7. ncbi C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation
    Cinzia Cianfrocca
    Department of Cardiology, San Filippo Neri Hospital, Rome, Italy
    Int J Cardiol 142:22-8. 2010
  8. ncbi Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions
    Leonardo Calo
    Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
    Ital Heart J 4:430-41. 2003
  9. ncbi Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial
    Marcello Disertori
    Department of Cardiology, Santa Chiara Hospital, Trento, Italy
    Am Heart J 162:382-9. 2011
  10. ncbi New antiarrhythmic drugs for the treatment of atrial fibrillation
    Antonio Castro
    Department of Heart Disease, S. Filippo Neri Hospital, Rome, Italy
    Pacing Clin Electrophysiol 25:249-59. 2002

Detail Information

Publications10

  1. ncbi n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study
    Leopoldo Bianconi
    Department of Cardiology, San Filippo Neri Hospital, University of Tor Vergata, Rome, Italy
    Europace 13:174-81. 2011
    ....
  2. ncbi Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination
    Leonardo Calo
    Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
    Ital Heart J 4:442-7. 2003
    ....
  3. ncbi Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: a prospective and randomized study
    Leonardo Calo
    Division of Cardiology, Policlinico Casilino, ASL RM B, Rome, Italy
    J Am Coll Cardiol 47:2504-12. 2006
    ..The aim of this study was to compare--in patients with persistent and permanent atrial fibrillation (AF)--the efficacy and safety of left atrial ablation with that of a biatrial approach...
  4. ncbi Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion
    Maria Luisa Loricchio
    Cardiology Department, Sandro Pertini Hospital, Rome, Italy
    Am J Cardiol 99:1421-4. 2007
    ..98, 95% confidence interval 1.75 to 14.26, p = 0.003). In conclusion, low CRP is associated with long-term maintenance of sinus rhythm after cardioversion for nonvalvular AF...
  5. ncbi Atrial flutter and atrial fibrillation: which relationship? New insights into the electrophysiological mechanisms and catheter ablation treatment
    Leonardo Calo
    Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
    Ital Heart J 6:368-73. 2005
    ..Also, atypical right and left AFL can determine AF. Finally, atypical AFL may occur after AF ablation, and could be prevented by associated cavotricuspid isthmus ablation...
  6. ncbi N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial
    Leonardo Calo
    Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
    J Am Coll Cardiol 45:1723-8. 2005
    ....
  7. ncbi C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation
    Cinzia Cianfrocca
    Department of Cardiology, San Filippo Neri Hospital, Rome, Italy
    Int J Cardiol 142:22-8. 2010
    ..We studied the correlation between inflammation and the risk of thrombogenesis in patients with AF and the relationship of inflammation with other factors associated with thrombotic risk...
  8. ncbi Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions
    Leonardo Calo
    Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy
    Ital Heart J 4:430-41. 2003
    ..In part I of the review we try to give a unified vision of the old models and new concepts about the molecular and ionic fundamentals of antiarrhythmic drug actions...
  9. ncbi Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial
    Marcello Disertori
    Department of Cardiology, Santa Chiara Hospital, Trento, Italy
    Am Heart J 162:382-9. 2011
    ..In a consistent percentage of cases, AF recurrences are asymptomatic, thus making its clinical management difficult in relation to both therapeutic efficacy and thromboembolic risk...
  10. ncbi New antiarrhythmic drugs for the treatment of atrial fibrillation
    Antonio Castro
    Department of Heart Disease, S. Filippo Neri Hospital, Rome, Italy
    Pacing Clin Electrophysiol 25:249-59. 2002